Ethel Cesarman

The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Epstein-Barr virus (EBV) and lymphomagenesis.

Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.

Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma.

The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.

Alterations of mRNA splicing in primary effusion lymphomas.

Pathogenesis of Kaposi's sarcoma.

Kaposi's sarcoma-associated herpesvirus--the high cost of viral survival.

KSHV vFLIP is essential for the survival of infected lymphoma cells.

KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma.

Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis.

Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association.

Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA.

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling.

NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.

Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

Pathogenesis of viral lymphomas.

beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia.

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.

Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.

Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma.

HIV-associated lymphomas and gamma-herpesviruses.

The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic.

Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.

Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

NF-kappaB signaling modulation by EBV and KSHV.

Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.

NF-κB as a target for oncogenic viruses.

Kaposi's sarcoma and its associated herpesvirus.

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.

A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.

Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study.

Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D.

Viral lymphomas: can antivirals be used to treat cancer?

Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.

Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles.

Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.

Pathology of lymphoma in HIV.

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.

The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1.

Gammaherpesviruses and lymphoproliferative disorders.

Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics.

How do viruses trick B cells into becoming lymphomas?

Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessory.

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.

KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo.

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo.

The tumor virus landscape of AIDS-related lymphomas.

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples.

Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

The epichaperome is an integrated chaperome network that facilitates tumour survival.

Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.